| Literature DB >> 21116448 |
Joshua G McCoy1, Juan J Marugan, Ke Liu, Wei Zheng, Noel Southall, Wenwei Huang, Markus Heilig, Christopher P Austin.
Abstract
Antagonists of the Neuropeptide S Receptor have been postulated as promising therapeutics in the treatment of respiratory, sleep, anxiety, and addictive disorders. Here we present the SAR of a new series of orthosteric antagonists. Neuropeptide S Receptor signaling is coupled to both Gq and Gs proteins, and we observe that different analogues in this structural series can selectively antagonize these two pathways. Many G-protein coupled receptors transduce signals through multiple pathways. Selective antagonism of these pathways may lead the way to the development of more targeted pharmacological profiles and therapies.Entities:
Year: 2010 PMID: 21116448 PMCID: PMC2992437 DOI: 10.1021/cn100040h
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418